Lonza names Roche executive as CEO, underscoring pharmaceuticals focus

ZURICH (Reuters) - Swiss contract drug manufacturer Lonza Group on Friday named Roche manager Pierre-Alain Ruffieux as its new chief executive, effective Nov. 1, underscoring its focus on its fast-growing pharmaceuticals business.Lonza said this week it aimed to speed up work on two commercial production lines for Moderna Inc's trial COVID-19 vaccine so manufacturing could start earlier this year than planned if the project is successful.Ruffieux, 50, is now the head of global pharma technical..